Bank of Montreal’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,697
Closed -$145K 5239
2020
Q3
$145K Sell
1,697
-1,109
-40% -$56.1K ﹤0.01% 2895
2020
Q2
$120K Buy
2,806
+214
+8% +$6.26K ﹤0.01% 3008
2020
Q1
$27K Sell
2,592
-22,166
-90% -$373K ﹤0.01% 3142
2019
Q4
$524K Buy
24,758
+8,873
+56% +$157K ﹤0.01% 2646
2019
Q3
$211K Buy
15,885
+199
+1% +$2.92K ﹤0.01% 2872
2019
Q2
$218K Buy
15,686
+15,154
+2,848% +$228K ﹤0.01% 2875
2019
Q1
$10K Sell
532
-2,143
-80% -$34.5K ﹤0.01% 3888
2018
Q4
$38K Buy
2,675
+284
+12% +$5.64K ﹤0.01% 3399
2018
Q3
$49K Sell
2,391
-6,419
-73% -$152K ﹤0.01% 3404
2018
Q2
$209K Buy
8,810
+870
+11% +$17.5K ﹤0.01% 2734
2018
Q1
$116K Buy
7,940
+1,740
+28% +$28.4K ﹤0.01% 2894
2017
Q4
$100K Sell
6,200
-8,450
-58% -$99.7K ﹤0.01% 3003
2017
Q3
$205K Buy
14,650
+14,000
+2,154% +$140K ﹤0.01% 2659
2017
Q2
$6K Buy
650
+210
+48% +$1.48K ﹤0.01% 3848
2017
Q1
$3K Hold
440
﹤0.01% 3793
2016
Q4
$1K Hold
440
﹤0.01% 4000
2016
Q3
$1K Hold
440
﹤0.01% 3967
2016
Q2
$1K Sell
440
-343
-44% -$1.15K ﹤0.01% 4017
2016
Q1
$2K Hold
783
﹤0.01% 3998
2015
Q4
$2K Buy
+783
New +$2.19K ﹤0.01% 4015
2014
Q3
Sell
-1,840
Closed -$7K 4576
2014
Q2
$7K Buy
+1,840
New +$6.75K ﹤0.01% 4034

Bank of Montreal's IMMU Position: Q4 2020 in Review

Bank of Montreal sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,697 shares — an estimated $145K sold.

Bank of Montreal first reported a position in IMMU in Q2 2014 and held it in 21 quarters. The position peaked at $524K in Q4 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Bank of Montreal reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Bank of Montreal sold 1,697 Immunomedics Inc shares in Q4 2020, an estimated $145K.
  • Bank of Montreal first reported a position in Immunomedics Inc in Q2 2014 and held it in 21 quarters.
  • Bank of Montreal's Immunomedics Inc position peaked at $524K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.